CollPlant Biotechnologies (CLGN) Price to Book (2018 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Price to Book came in at 0.29 in Q4 2025, down 3.75% on a YoY basis from 0.31 in Q4 2024, and down 10.99% quarter-over-quarter from 0.33 in Q3 2025.
Analysis
CollPlant Biotechnologies (CLGN) Price to Book (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has reported Price to Book for 8 consecutive years, with 0.29 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Price to Book fell 3.75% year-over-year to 0.29; the trailing twelve-month figure through Dec 2025 stood at 0.29 (down 3.75% YoY), and the FY2025 full-year result was 0.29, down 3.75% from the prior year.
- Price to Book eased to 0.29 in Q4 2025 per CLGN's latest filing, from 0.33 in the prior quarter.
- Across five years, Price to Book topped out at 0.39 in Q4 2021 and bottomed at 0.12 in Q2 2025.
- Historically, Price to Book has averaged 0.26 across 5 years, with a median of 0.26 in 2023.
- The sharpest annual moves came in 2021 and 2024: Price to Book tumbled 76.69% in 2021, then surged 74.94% in 2024.
- Over 5 years, Price to Book stood at 0.39 in 2021, then fell by 25.91% to 0.29 in 2022, then dropped by 10.76% to 0.26 in 2023, then rose by 18.59% to 0.31 in 2024, then declined by 3.75% to 0.29 in 2025.
- According to Business Quant data, Price to Book over the past three periods registered 0.29, 0.33, and 0.12 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | CollPlant Biotechnologies | 4.17 Mn | 4.17 Mn | -243,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.29 |
| Sep 30, 2025 | 0.33 |
| Jun 30, 2025 | 0.12 |
| Dec 31, 2024 | 0.31 |
| Sep 30, 2024 | 0.34 |
| Jun 30, 2024 | 0.27 |
| Mar 31, 2024 | 0.25 |
| Dec 31, 2023 | 0.26 |
| Sep 30, 2023 | 0.19 |
| Jun 30, 2023 | 0.25 |
| Mar 31, 2023 | 0.26 |
| Dec 31, 2022 | 0.29 |
| Sep 30, 2022 | 0.20 |
| Jun 30, 2022 | 0.22 |
| Mar 31, 2022 | 0.28 |
| Dec 31, 2021 | 0.39 |
| Sep 30, 2021 | 0.24 |
| Jun 30, 2021 | 0.30 |
| Mar 31, 2021 | 0.18 |
| Dec 31, 2020 | 1.68 |